Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 15, Issue 4, Pages 213-220
http://dx.doi.org/10.1155/2004/383461
Original Article

The Costs and Consequences of Methicillin-Resistant Staphylococcus aureus Infection Treatments in Canada

Andrew J Rosner,1 Debbie L Becker,1 Angelina H Wong,2 Elizabeth Miller,2 and John M Conly3

1Health Economics and Outcomes Research, Innovus Research Inc, Burlington, Ontario, Canada
2Patient Access and Outcomes Research, Pharmacia Canada, Mississauga, Ontario, Canada
3Division of Infectious Diseases, Department of Medicine, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada

Received 30 October 2003; Accepted 12 June 2004

Copyright © 2004 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Andrew J Rosner, Debbie L Becker, Angelina H Wong, Elizabeth Miller, and John M Conly, “The Costs and Consequences of Methicillin-Resistant Staphylococcus aureus Infection Treatments in Canada,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 15, no. 4, pp. 213-220, 2004. https://doi.org/10.1155/2004/383461.